Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at PLN 382.3B, ahead of Eli Lilly (PLN 264.6B) and Merck & Co (PLN 263.9B). Figures as of 20 Nov 2026, 16:33 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonPLN 382.3B
- Median
- PLN 5.6B
- Combined market value
- PLN 15.28T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 382.3B | PLN 2.65T | PLN 1,100.96 | 1.53% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 264.6B | PLN 4.89T | PLN 5,492.15 | 0.15% up | 28% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 263.9B | PLN 1.35T | PLN 549.14 | 1.87% up | 36% up | ||
| 4 | PfizerPFE · Health Care | PLN 254B | PLN 640.6B | PLN 112.39 | 0.54% up | 10% up | ||
| 5 | AbbVieABBV · Health Care | PLN 248.2B | PLN 2.07T | PLN 1,169.52 | 1.62% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | PLN 195.6B | PLN 493.4B | PLN 241.37 | 1.93% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | PLN 179.9B | PLN 732.6B | PLN 422.97 | 0.32% up | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | PLN 58.2B | PLN 391.5B | PLN 3,784.77 | 1.09% up | 22% up | ||
| 9 | ViatrisVTRS · Health Care | PLN 58B | PLN 91.1B | PLN 79.43 | 1.56% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | PLN 48.7B | PLN 539.9B | PLN 2,129.46 | 0.76% up | 22% up | ||
| 11 | ZoetisZTS · Health Care | PLN 38.4B | PLN 134B | PLN 329.71 | 0.54% up | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | PLN 19.1B | PLN 52.8B | PLN 105.64 | 1.01% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | PLN 15.1B | PLN 81.5B | PLN 608.44 | 1.41% up | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | PLN 13.1B | PLN 48B | PLN 247.64 | 0.67% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | PLN 12.9B | PLN 96B | PLN 2,254.96 | 0.64% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | PLN 12.3B | PLN 30B | PLN 86.01 | 0.94% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | PLN 9.7B | PLN 160B | PLN 278.18 | 1.20% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | PLN 7B | PLN 19.6B | PLN 234.39 | 0.99% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | PLN 4.2B | PLN 12.4B | PLN 63.97 | 2.11% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 3.9B | PLN 36.8B | PLN 1,583.94 | 1.64% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | PLN 3.8B | PLN 18.6B | PLN 111.62 | 1.03% up | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 3.4B | PLN 24.7B | PLN 174.50 | 1.51% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | PLN 3.1B | PLN 28.3B | PLN 258.66 | 1.93% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | PLN 2.6B | PLN 27.9B | PLN 530.15 | 3.74% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | PLN 2.5B | PLN 39.5B | PLN 261.66 | 0.64% down | 103% up | ||
| 26 | InsmedINSM · Health Care | PLN 2.5B | PLN 129.1B | PLN 588.56 | 0.37% up | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | PLN 2.1B | PLN 26B | PLN 397.66 | 2.58% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | PLN 2B | PLN 61.1B | PLN 313.62 | 1.17% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | PLN 2B | PLN 18.9B | PLN 196.58 | 0.27% up | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | PLN 1.1B | PLN 23.4B | PLN 1,169.85 | 0.44% up | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 770.2M | PLN 32B | PLN 461.02 | 2.76% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | PLN 357.4M | PLN 29.4B | PLN 211.01 | 1.02% up | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | PLN 186.8M | PLN 32.5B | PLN 497.45 | 1.18% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | PLN 8.3M | PLN 19.3B | PLN 342.42 | 0.55% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | PLN 0 | PLN 36.7B | PLN 386.90 | 2.37% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | PLN 0 | PLN 34.6B | PLN 1,239.09 | 1.81% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0590 PLN). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (PLN 382.3B), Eli Lilly (PLN 264.6B) and Merck & Co (PLN 263.9B) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 16:33 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of PLN 15.28T as of 20 Nov 2026, 16:33 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.